Evidence map›Paper›PMID 31949268›Full record

ArticleBritish journal of cancer2020

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

Karin Ribi, Weixiu Luo, Marco Colleoni, Per Karlsson, Jacquie Chirgwin, Stefan Aebi, Guy Jerusalem, Patrick Neven, Vincenzo Di Lauro, Henry L Gomez and 20 more

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 19 institutions in 8 countries.

Karin RibiQuality of Life Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.
Weixiu LuoInternational Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Marco ColleoniDivision of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Per KarlssonDepartment of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy/Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Jacquie ChirgwinBox Hill and Maroondah Hospitals, Monash University, Victoria, Australia.
Stefan AebiLuzerner Kantonsspital, Lucerne, Switzerland.
Guy JerusalemCHU Liège, Liège University, Liège, Belgium.
Patrick NevenMultidisciplinary Breast Center, University Hospitals, KU Leuven, Leuven, Belgium.
Vincenzo Di LauroDivision of Medical Oncology B, CRO-Aviano, Aviano, Italy.
Henry L GomezInstituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Thomas RuhstallerBreast Center St. Gallen, Swiss Group for Clinical Cancer Research and International Breast Cancer Study Group, Bern, Switzerland.
Ehtesham AbdiThe Tweed Hospital, Tweed Heads, NSW & Griffith University Gold Coast, Southport, Australia.
Laura BiganzoliHospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy.
Bettina MüllerChilean Cooperative Group for Oncologic Research (GOCCHI), Providencia, Santiago, Chile.
Annelore BarbeauxCHR Verviers, Verviers, Belgium.
Marie-Pascale GraasCHC Clinique St. Joseph, Liège, Belgium.
Manuela RabaglioBern University Hospital, Inselspital, Bern, Switzerland.
Prudence A FrancisPeter MacCallum Cancer Center, University of Melbourne, Melbourne and Breast Cancer Trials Australia & New Zealand, University of Newcastle, Newcastle, Australia.
Theodoros FoukakisDepartment of Oncology, Karolinska Institute and University Hospital, Stockholm, Sweden.
Olivia PaganiInstitute of Oncology of Southern Switzerland, Bellinzona, Geneva University Hospitals, Geneva, Swiss Group for Clinical Cancer Research (SAKK) and International Breast Cancer Study Group, Bern, Switzerland.
Claudio GraiffDivision of Medical Oncology, Ospedale Centrale di Bolzano, Bolzano, Italy.
Daniel VorobiofSandton Oncology Centre, Johannesburg, South Africa.
Rudolf MaibachInternational Breast Cancer Study Group Coordinating Center, Bern, Switzerland.
Angelo Di LeoHospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy.
Richard D GelberInternational Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA.
Aron GoldhirschInternational Breast Cancer Study Group and IEO, European Institute of Oncology IRCCS, Milan, Italy.
Alan S CoatesInternational Breast Cancer Study Group and University of Sydney, Sydney, Australia.
Meredith M ReganInternational Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Jürg BernhardQuality of Life Office, International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. juerg.bernhard@ibcsg.org.
SOLE Investigators
International Breast Cancer Study Group · CHDana-Farber Cancer Institute · USBreast Cancer Trials · AUEuropean Institute of Oncology · ITHospital of Prato · ITUniversity Hospital of Bern · CHCentro di Riferimento Oncologico · ITCHR Verviers · BEClinique Saint-Joseph · BEGriffith University · AUInstituto Nacional de Enfermedades Neoplásicas · PEKarolinska University Hospital · SEKU Leuven · BELuzerner Kantonsspital · CHMonash University · AUOspedale di Bolzano · ITSahlgrenska University Hospital · SEThe Medical Oncology Centre of Rosebank · ZAUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31949268
PMCPMC7109133
OpenAlexW2939036871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.